FCG Advisors’s Opus Genetics IRD Stock Holding History

FCG Advisors’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-31	Closed	-$11K	–	112
2014 Q4	$11K	Hold	31	–	–	0.01%	108
2014 Q3	$12K	Buy	+31	New	+$11.2K	0.01%	78

Other funds holding IRD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CCM

Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

FCG Advisors's IRD Position: Q1 2015 in Review

FCG Advisors sold out of Opus Genetics (IRD) in Q1 2015, closing a stake of 31 shares — an estimated $11K sold.

FCG Advisors first reported a position in IRD in Q3 2014 and held it in 2 quarters. The position peaked at $12K in Q3 2014. 35 funds tracked by Wall St. Rank hold IRD as of Q1 2015.

FCG Advisors reported no remaining Opus Genetics position as of Q1 2015 after selling out during the quarter.
FCG Advisors sold 31 Opus Genetics shares in Q1 2015, an estimated $11K.
FCG Advisors first reported a position in Opus Genetics in Q3 2014 and held it in 2 quarters.
FCG Advisors's Opus Genetics position peaked at $12K in Q3 2014.
35 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2015.

Based on FCG Advisors's 13F filing for Q1 2015, filed 14 May 2015.